2AD 2mg*10vials

AOD9604 2AD 2mg*10vials

AOD9604 is a modified fragment of human growth hormone, specifically designed to target fat metabolism without the growth-related side effects associated with full-length HGH. It represents a specialized research peptide focused on lipolytic pathways.

The 2mg single-vial specification is the standard concentration, ideal for initial dose-response studies, short-term fat metabolism mechanism experiments, and researchers conducting foundational lipolysis research. This low-dose format offers flexibility in experimental design, allowing researchers to explore a wide range of dose levels while minimizing excessive active compound usage.

Through its targeted receptor pathway, AOD9604 supports research into fat oxidation, lipolysis mechanisms, and metabolic regulation related to adipose tissue breakdown. It is designed to study fat mobilization pathways without influencing blood sugar levels or muscle growth parameters.

This product is supplied as sterile lyophilized powder in glass vials, prepared for reconstitution with bacteriostatic water. Each batch undergoes rigorous purity testing, with a certificate of analysis provided.

10 vials per pack, suitable for routine laboratory research and foundational fat metabolism studies.